Literature DB >> 10443627

An unexpected hyperkalemic response to succinylcholine during electroconvulsive therapy for catatonic schizophrenia.

R C Cooper1, P L Baumann, W M McDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10443627     DOI： 10.1097/00000542-199908000-00038

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  5 in total

Review 1.  Anesthetic care for electroconvulsive therapy.

Authors:  Kyoung-Woon Joung; Dong Ho Park; Chang Young Jeong; Hong Seuk Yang
Journal:  Anesth Pain Med (Seoul)       Date:  2022-04-15

2.  Rocuronium and sugammadex: An alternative to succinylcholine for electro convulsive therapy in patients with suspected neuroleptic malignant syndrome.

Authors:  Karthik G Ramamoorthy; H Downey; P Hawthorne
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-07

3.  Propofol-remifentanil combination for management of electroconvulsive therapy in a patient with neuroleptic malignant syndrome.

Authors:  Modabber Arasteh; Shoaleh Shami; Karim Nasseri
Journal:  Case Rep Med       Date:  2012-04-03

4.  Comparison between succinylcholine and rocuronium as neuromuscular blocking agents for electroconvulsive therapy in a patient with pseudocholinesterase deficiency.

Authors:  Tomonori Takazawa; Takashi Suto; Masako Aihara; Takeshi Anzai; Tatsuo Horiuchi; Makiko H Yamada; Yuji Kadoi; Shigeru Saito
Journal:  JA Clin Rep       Date:  2015-08-27

5.  Use of sugammadex in parotid surgery: a case report.

Authors:  Mustapha Bensghir; Abdelghafour Elkoundi; Redouane Ahtil; Mohammed Meziane; Charki Haimeur
Journal:  J Med Case Rep       Date:  2016-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.